Menu
Gibson Lab
Impact

You are here

Home > Faculty & Research > Gibson Lab > Impact
Browse by
Publications
Presentations
News Articles
Grants

Featured News

Gibson Lab
NEWS: 
Press Release
January 7, 2025
Decades of Research Leads to Promising Clinical Trial for Early Alzheimer’s Treatment

Dr. Gary Gibson, Director of the Laboratory for Mitochondrial Biology and Metabolic Dysfunction in Neurodegeneration at the Burke Neurological Institute, has dedicated his career to advancing Alzheimer’s disease research.

Gibson Lab
NEWS: 
In the Media
September 24, 2024
Innovative Alzheimer’s Research: Dr. Gary Gibson Discusses Multi-Site Clinical Trial on ABC 7 News

We are thrilled to highlight Dr.

See all news >

Publications

Gibson Lab
PUBLICATION: 
Review
Hussein N. Yassine,Wade Self,Bilal E. Kerman,Giulia Santoni,NandaKumar Navalpur Shanmugam,Laila Abdullah,Lesley R. Golden,Alfred N. Fonteh,Michael G. Harrington,Johannes Gräff,Gary E. Gibson,Raj Kalaria,Jose A. Luchsinger,Howard H. Feldman,Russell H. Swerdlow,Lance A. Johnson,Benedict C. Albensi,Berislav V. Zlokovic,Rudolph Tanzi,Stephen Cunnane,Cécilia Samieri,Nikolaos Scarmeas,Gene L. Bowman,Nutrition, Metabolism and Dementia PIA, Alzheimer's Association ISTAART
Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias
Alzheimers Dement. 2022 Dec 8. doi: 10.1002/alz.12845. Online ahead of print.
Full Text on Wiley
Gibson Lab
PUBLICATION: 
Review
Grace E Hansen, Gary E Gibson
The α-Ketoglutarate Dehydrogenase Complex as a Hub of Plasticity in Neurodegeneration and Regeneration
Int J Mol Sci. 2022 Oct 17;23(20):12403. doi: 10.3390/ijms232012403.
Full-Text on PMC
Gibson Lab
PUBLICATION: 
Opinion Article
Gary E Gibson, Howard H Feldman, Sheng Zhang, Sarah A Flowers, José A Luchsinger
Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease
Front Med (Lausanne). 2022 Oct 4;9:1033272. doi: 10.3389/fmed.2022.1033272. eCollection 2022.
Full-Text on Frontiers
See all publications >

Grants

Gibson Lab
GRANT: 
Federal
April 15, 2016 to March 31, 2021
The Tricarboxylic Acid (Tca) Cycle in Neurodegeneration
Funding Status: 
Active Project
National Institutes of Health (NIH)
National Institute on Aging (NIA)
Grant Number: 
P01AG014930
Investigators: 
Gary E. Gibson, Ph.D.
Project Leader
Gibson Lab
GRANT: 
Federal
September 1, 2014 to May 31, 2019
Benfotiamine in Alzheimer's Disease: A Pilot Study (Benfotiamine)
Funding Status: 
Completed Project
National Institutes of Health (NIH)
National Institute on Aging (NIA)
Grant Number: 
R01AG043679
Investigators: 
Gary E. Gibson, Ph.D.
Principal Investigator
Pasquale Fonzetti, M.D., Ph.D.
Principal Investigator
See all grants >

Presentations

Gibson Lab
PRESENTATION: 
Poster Presentation
June 5, 2022
CHIMERYS search engine with deep mining of chimeric spectra for enhanced in-depth brain proteome in Alzheimer’s Disease
Venue: 
American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics in Minneapolis
Featured Researchers: 
Gary E. Gibson, Ph.D.
See all presentations >